The Cost of Compassion: Drug Pricing and the Economics of Rare Diseases
Key Takeaways
Orphan drugs are scientifically powerful—but financially overwhelming.
Access is nearly nonexistent in LMICs due to high costs and import barriers.
Ethical tensions include affordability, fairness, and…